More about

Lymphoma

News
September 04, 2020
1 min read
Save

Top in GI: Antibiotics and IBD, anti-TNF and lymphoma risk

Top in GI: Antibiotics and IBD, anti-TNF and lymphoma risk

Higher cumulative exposure to systemic antibiotic therapy was associated with an increased risk for inflammatory bowel disease, according to a recent study. It was the top story in gastroenterology last week.

News
August 27, 2020
1 min read
Save

Top in hem/onc: Aspirin and cancer, breast implants and lymphoma

Top in hem/onc: Aspirin and cancer, breast implants and lymphoma

A new study showed that aspirin use may accelerate the progression of cancer among older adults. It was the top story in hematology/oncology last week.

News
August 26, 2020
1 min read
Save

Anti-TNF, thiopurine combination increase lymphoma risk in IBD

Patients with inflammatory bowel disease treated with anti-TNF either as a monotherapy or in combination with thiopurines are at increased risk for lymphoma, according to study results.

News
August 21, 2020
2 min read
Save

FDA identifies more cases of lymphoma linked to breast implants

FDA identifies more cases of lymphoma linked to breast implants

The number of lymphoma cases linked to breast implants increased nearly 28% in the second half of last year, according to the FDA.

News
July 23, 2020
2 min read
Save

Atopic eczema may be associated with lymphoma risk

Atopic eczema carried no association with overall cancer risk but was associated with non-Hodgkin and Hodgkin lymphoma, according to results of two large population-based studies.

News
July 22, 2020
1 min read
Save

New model further stratifies risk in mantle cell lymphoma

The North American Mantle Cell Consortium stratified nearly 600 patients with mantle cell lymphoma to offer characteristics and risk factors for stratification, according to one presenter at ASCO20 Virtual Scientific Program.

News
July 22, 2020
1 min read
Save

Anti-CD20 treatment switch effective, more successful than desensitization

Switching a B-cell lymphoma or leukemia treatment from CD20-directed immunotherapy to an alternative option may offer a successful alternative to desensitization protocols in instances of severe drug hypersensitivity.

News
July 21, 2020
1 min read
Save

Triple therapy has comparable results in relapsed/refractory B-cell lymphoma

Atezolizumab, obinutuzumab and venetoclax combined produced a durable response in relapsed/refractory diffuse large B-cell lymphoma but presented best in low tumor burden cases, according to a poster presented at ASCO20 Virtual Scientific Sessions.

News
July 21, 2020
1 min read
Save

Transformed indolent lymphoma benefits from stem cell transplant at first remission

Autologous stem cell transplant at first remission for untreated transformed indolent B-cell lymphoma improved duration of disease control but showed trends toward worse overall survival, according to a presenter at ASCO2020 Virtual Scientific Program.

News
July 18, 2020
2 min read
Save

Fox Chase Cancer Center announces faculty appointments

Fox Chase Cancer Center announced several faculty appointments.

View more